Waystar (NASDAQ:WAY) Upgraded by Barclays to Strong-Buy Rating

Waystar (NASDAQ:WAYGet Free Report) was upgraded by stock analysts at Barclays to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

WAY has been the subject of a number of other research reports. Truist Financial dropped their price objective on Waystar from $51.00 to $38.00 and set a “buy” rating for the company in a research note on Wednesday, February 18th. The Goldman Sachs Group dropped their price objective on Waystar from $44.00 to $38.00 and set a “buy” rating for the company in a research note on Wednesday, February 18th. Leerink Partners initiated coverage on Waystar in a research note on Monday, February 2nd. They issued an “outperform” rating and a $43.00 price objective for the company. Canaccord Genuity Group dropped their price objective on Waystar from $54.00 to $30.00 and set a “buy” rating for the company in a research note on Wednesday, February 18th. Finally, Loop Capital set a $33.00 price objective on Waystar in a research note on Wednesday, February 18th. Four analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $35.62.

View Our Latest Report on WAY

Waystar Stock Performance

NASDAQ WAY opened at $19.21 on Wednesday. The firm has a market cap of $3.68 billion, a price-to-earnings ratio of 28.67, a price-to-earnings-growth ratio of 0.78 and a beta of 0.21. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.37. The business has a 50-day moving average price of $23.09 and a 200-day moving average price of $28.09. Waystar has a twelve month low of $17.89 and a twelve month high of $41.49.

Waystar (NASDAQ:WAYGet Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.03. The firm had revenue of $313.87 million during the quarter, compared to analyst estimates of $311.74 million. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The business’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.32 earnings per share. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. As a group, equities research analysts predict that Waystar will post 1.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Waystar

A number of institutional investors and hedge funds have recently modified their holdings of WAY. Royal Bank of Canada lifted its stake in shares of Waystar by 11.3% during the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock worth $808,000 after acquiring an additional 2,195 shares during the last quarter. AQR Capital Management LLC purchased a new stake in shares of Waystar in the 1st quarter worth $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Waystar by 91.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock worth $1,753,000 after buying an additional 22,364 shares during the period. NewEdge Advisors LLC purchased a new stake in shares of Waystar in the 1st quarter worth $234,000. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Waystar by 13.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock worth $27,918,000 after buying an additional 88,256 shares during the period.

Waystar Company Profile

(Get Free Report)

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.

See Also

Analyst Recommendations for Waystar (NASDAQ:WAY)

Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.